Former DOJ officials warn of ‘big health care’ monopolies
Experts warn that expanding health care conglomerates threaten competition, increase costs and limit independent practitioners’ autonomy, urging regulatory action.
Related Articles
Supporting medical science in the USA
The pursuit of rigorous medical science is not compatible with capitulation to government demands aimed at weaponising and eroding science. On April 14, Edwin R…
Study: Antibiotic Allergy Delabeling Is Feasible and Safe With Few Adverse Events
The smartphone application-led delabeling also did not delay surgeries or procedures in the evaluated clinics.
New for 2025: Software Advice’s EMR Software Pricing Guide
Don’t let hidden expenses eat through your budget. This helpful pricing guide shows you what to expect.
Diazepam Nasal Spray Receives FDA Approval for Seizure Clusters in Individuals 2 Years and Older
The safety profile of diazepam nasal spray among pediatric patients was consistent with older patients, supporting its use in this age group.
Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor (CoGNET)
This 2-cm mass was identified in the second portion of the duodenum in an adult. Pathologic examination diagnosed the tumor as a composite gangliocytoma/neuroma and…
The 7 secrets of a fulfilling medical career
Discover seven evidence-based strategies to reignite your passion for medicine and combat burnout, ensuring a fulfilling and sustainable career.
Surveillance, Targeted Interventions Critical to Combat Variable Nature of Invasive Pneumococcal Disease
Invasive pneumococcal disease trends have fluctuated greatly over the last 2 decades, with older adults remaining at the center of disease burden.
ACP Advocate | ACP Online
The ACP Advocate is a bi-weekly e-newsletter that provides ACP members with news about public policy issues affecting internal medicine.
Trastuzumab Deruxtecan Plus Pertuzumab Improves Progression-Free Survival in Patients With HER2+ Metastatic Breast Cancer
The meaningful results were reported in the DESTINY-Breast09 trial.
Safety of RTS,S/AS01E malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring study
We found no evidence of vaccination being associated with an increased risk of meningitis, cerebral malaria, or mortality among vaccinated children, and no new safety…